Company Filing History:

9 out of 197

Boehringer Ingelheim Kg

patents

6 out of 149

Boehringer Ingelheim Pharma Kg

patents

2 out of 306

Boehringer Ingelheim Gmbh

patents

Years Active: 1989-2002

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6492407 - Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones (2002-12-10),

2. 6455538 - 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols (2002-09-24),

3. 6441237 - Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines (2002-08-27),

4. 6277872 - Oxadiazoles, processes for their preparation and their use as medicaments (2001-08-21),

5. 6255327 - Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions (2001-07-03),

6. 6245777 - N-(5-phenyl-tetrahydrofuranyl)methyl- and N-(6-phenyl-tetrahydropyranyl)methyl-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols (2001-06-12),

7. 6051583 - 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for (2000-04-18),

8. 5783576 - Benzoyl guanidine derivatives, the preparation thereof and their use in (1998-07-21),

9. 5698552 - Hetrazepinoid amides (1997-12-16),

10. 5532233 - Hetrazepine compounds which have useful pharmaceutical utility (1996-07-02),

11. 5217967 - Agent with an antidepressant activity (1993-06-08),

12. 5185442 - New diazepines substituted in the 6-position, processes for their (1993-02-09),

13. 5116971 - Substituted-1,4-diazepines (1992-05-26),

14. 4954516 - Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants (1990-09-04),

15. 4912129 - Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants (1990-03-27),

Title: Wolf-Dietrich Bechtel: A Visionary Inventor Shaping the Future

Introduction:

Wolf-Dietrich Bechtel, a renowned inventor hailing from Appenheim, Germany, has left an indelible mark on the world of innovation. With a total of 17 patents to his name, his dedication to excellence and passion for creating a better future through his inventions truly sets him apart as a visionary in his field.

Latest Patents:

Among his latest patents is the groundbreaking work on pharmaceutical compositions containing triazolones and methods for treating neurodegenerative diseases using triazolones. Additionally, his research on 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols showcases his innovative approach towards advancing healthcare solutions.

Career Highlights:

Throughout his career, Wolf-Dietrich Bechtel has made significant contributions while working at Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG. His expertise and commitment to pushing the boundaries of scientific discovery have led to the development of groundbreaking technologies that have the potential to revolutionize various industries.

Collaborations:

Collaborating with esteemed professionals such as Karl-Heinz Weber and Thomas Weiser has further enriched Wolf-Dietrich Bechtel's innovative journey. Together, they have shared ideas, insights, and expertise, fostering a culture of innovation and pushing the boundaries of what is possible in the world of inventions.

Conclusion:

In conclusion, Wolf-Dietrich Bechtel's unwavering dedication to innovation, coupled with his prolific track record of patents and collaborative spirit, solidify his position as a trailblazer in the field of inventors. His contributions continue to shape the future of technology and healthcare, inspiring generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com